AU2018900324A0 - Oral Formulations and Uses Thereof - Google Patents

Oral Formulations and Uses Thereof

Info

Publication number
AU2018900324A0
AU2018900324A0 AU2018900324A AU2018900324A AU2018900324A0 AU 2018900324 A0 AU2018900324 A0 AU 2018900324A0 AU 2018900324 A AU2018900324 A AU 2018900324A AU 2018900324 A AU2018900324 A AU 2018900324A AU 2018900324 A0 AU2018900324 A0 AU 2018900324A0
Authority
AU
Australia
Prior art keywords
oral formulations
formulations
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900324A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eustralis Pharmaceuticals Ltd
Original Assignee
Eustralis Pharmaceuticals Ltd
Filing date
Publication date
Application filed by Eustralis Pharmaceuticals Ltd filed Critical Eustralis Pharmaceuticals Ltd
Publication of AU2018900324A0 publication Critical patent/AU2018900324A0/en
Priority to CA3089656A priority Critical patent/CA3089656A1/en
Priority to JP2020541731A priority patent/JP2021512869A/en
Priority to PCT/AU2019/050076 priority patent/WO2019148247A1/en
Priority to US16/966,289 priority patent/US20200368166A1/en
Priority to CN201980011256.3A priority patent/CN111670035A/en
Priority to EP19747749.0A priority patent/EP3746078A4/en
Priority to AU2019215802A priority patent/AU2019215802A1/en
Priority to MX2020008137A priority patent/MX2020008137A/en
Priority to ZA2020/05143A priority patent/ZA202005143B/en
Abandoned legal-status Critical Current

Links

AU2018900324A 2018-02-02 2018-02-02 Oral Formulations and Uses Thereof Abandoned AU2018900324A0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA3089656A CA3089656A1 (en) 2018-02-02 2019-02-01 Oral formulations and uses thereof
JP2020541731A JP2021512869A (en) 2018-02-02 2019-02-01 Oral preparation and its use
PCT/AU2019/050076 WO2019148247A1 (en) 2018-02-02 2019-02-01 Oral formulations and uses thereof
US16/966,289 US20200368166A1 (en) 2018-02-02 2019-02-01 Oral Formulations And Uses Thereof
CN201980011256.3A CN111670035A (en) 2018-02-02 2019-02-01 Oral preparation and use thereof
EP19747749.0A EP3746078A4 (en) 2018-02-02 2019-02-01 Oral formulations and uses thereof
AU2019215802A AU2019215802A1 (en) 2018-02-02 2019-02-01 Oral formulations and uses thereof
MX2020008137A MX2020008137A (en) 2018-02-02 2019-02-01 Oral formulations and uses thereof.
ZA2020/05143A ZA202005143B (en) 2018-02-02 2020-08-19 Oral formulations and uses thereof

Publications (1)

Publication Number Publication Date
AU2018900324A0 true AU2018900324A0 (en) 2018-02-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3706741A4 (en) Pharmaceutical composition and use thereof
EP3873440A4 (en) Polymer-based oral cannabinoid and/or terpene formulations
EP3876786A4 (en) Oral care implement
EP3946320A4 (en) Hsp90-binding conjugates and formulations thereof
EP3883994A4 (en) Solvent-free formulations and nanocomposites
EP3790861A4 (en) Senolytic compositions and uses thereof
EP3638251A4 (en) Bisphosphocin gel formulations and uses thereof
EP3746078A4 (en) Oral formulations and uses thereof
EP3723811A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3893694A4 (en) Oral care implement
EP3980009A4 (en) Modified release formulations and uses thereof
EP3691629A4 (en) Nutrient-spore formulations and uses thereof
EP3773670A4 (en) Hsp90-targeting conjugates and formulations thereof
EP3492466A4 (en) Oral solid preparation and use thereof
EP3687501A4 (en) Iniparib formulations and uses thereof
EP3644745A4 (en) Oral sweetener compositions and methods
EP3760616A4 (en) 4-methyldihydropyrimidinone compound and medicinal use thereof
EP3773654A4 (en) Polypharmaceutical drug compositions and related methods
EP3615008A4 (en) Hsp90 inhibitor oral formulations and related methods
EP3508193A4 (en) Oral composition and oral plaque dispersion agent
EP3697411A4 (en) Novel pharmaceutical composition and use thereof
EP3716766A4 (en) Benzoxaborole compounds and formulations thereof
EP3746077A4 (en) Parenteral formulations and uses thereof
EP3796915A4 (en) Oral formulations comprising rivaroxaban
EP3980008A4 (en) Modified release formulations and uses thereof